MedMen, weed dispensary, New York CitySarah Jacobs/Business Insider

MedMen, one of the booming cannabis industry’s most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction, the companies announced on Thursday.
It’s the largest cannabis acquisition in the US to date. 
The acquisition gives the combined firm access to 79 retail and cultivation licenses in 12 states. 

MedMen, one of the most recognizable brands in the rapidly expanding cannabis industry, acquired the medical marijuana dispensary chain PharmaCann in a $682 million all-stock transaction.

It’s the largest cannabis acquisition in the US to date. See the rest of the story at Business Insider

NOW WATCH: 3 compelling reasons why we haven’t found aliens yet

See Also:

An executive who led turnarounds at Victoria’s Secret and American Eagle reveals what the cannabis industry can learn from big retail brandsA former Coca-Cola executive and cannabis startup founder reveals the moment he knew cannabis would be ‘the next big thing’CEO of the beverage giant behind Corona: Cannabis is one of the ‘most significant’ growth opportunities of the next decade

SEE ALSO: We went inside Manhattan’s newest luxury marijuana dispensary on Fifth Avenue — and it’s stunning

SEE ALSO: A $1 billion dollar marijuana dispensary chain just opened a store on New York City’s fanciest shopping street — and it could signal a huge shift in the industry

Read more: